Introduction
============

In Japan, the average life expectancy has increased each year, having reached 80.77 years for men and 87.01 years for women by 2015\[[@B1]\]. Patients beyond 85 years of age are not uncommon at our hospital. Elderly people are typically plagued by more comorbidities and weaker immune systems, so postoperative complications may have devastating prognostic implications. Appropriate risk assessment is essential in their surgical treatment. The aim of this study was to explore scoring systems for predicting postoperative morbidity risk in super elderly patients (≥85 years old) surgically treated for colorectal cancer.

Methods
=======

A population of elderly patients (n = 145) submitting to primary colorectal cancer resection within our department between April 2007 and December 2018 were subjected to retrospective review. Emergency surgical procedures were grounds for exclusion, as were dual or multiple cancers. In the study participants, we examined the capacities of certain indices, such as Estimation of Physiologic Ability and Surgical Stress (E-PASS), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), prognostic nutritional index (PNI), and modified Glasgow Prognostic Score (mGPS), to predict postoperative complications.

E-PASS was first proposed by Haga et al. as a standard method of surgical risk assessment ([Figure 1](#g001){ref-type="fig"})\[[@B2]\]. The preoperative risk score (PRS) of E-PASS addresses the physiological state, whereas the surgical stress score (SSS) gauges the impact of surgical penetration. The comprehensive risk score (CRS) involves both PRS and SSS; the higher the score is, the greater the risk. NLR and PLR have also been identified as prognostic factors in various types of cancer, higher scores again denoting poorer prognoses\[[@B3],[@B4]\]. The PNI of Onodera et al. was originally intended for predicting risks of perioperative complications. PNI is calculated by the following formula: 10 × serum albumin (g/dL) + 0.005 × total lymphocytes/μL. A PNI score of ≤40 is an acknowledged contraindication for anastomosis\[[@B5]\]. C-reactive protein (CRP) and serum albumin are incorporated in the GPS. Jiang et al. (2015) have previously determined its prognostic value in patients with non-small cell lung cancer\[[@B6]\]. The mGPS ([Table 1](#t001){ref-type="table"}) was formulated in Japan by Miki et al., setting a CRP cutoff value of 0.5. This index has proven useful in predicting colorectal cancer outcomes\[[@B7]\], a higher score signaling a poor prognosis. This was a retrospective study. For statistical analysis, we performed chi-squared and Mann-Whitney *U* tests to examine the differences between the two groups. In order to control for confounding factors, binary logistic regression was used. The cumulative survival rate was analyzed with Kaplan-Meier and log-rank tests. P \< 0.05 was considered a statistically significant difference.

![Estimation of Physiologic Ability and Surgical Stress.](2432-3853-4-0137-g001){#g001}

###### 

Glasgow Prognostic Score (GPS) and Modified GPS (mGPS).

  GPS                                    Score
  -------------------------------------- -----------
  CRP ≤ 1.0 mg/dL and ALB ≥ 3.5 g/dL     0
  CRP \> 1.0 mg/dL or ALB \< 3.5 g/dL    1
  CRP \> 1.0 mg/dL and ALB \< 3.5 g/dL   2
  **mGPS**                               **Score**
  CRP ≤ 0.5 mg/dL and ALB ≥ 3.5 g/dL     0
  CRP \> 0.5 mg/dL or ALB \< 3.5 g/dL    1
  CRP \> 0.5 mg/dL and ALB \< 3.5 g/dL   2

CRP, C-reactive protein; ALB, albumin

The Ethics Committee of the Saitama Medical University International Medical Center approved the study that was conducted in accordance with the Helsinki Declaration of 1996. Also, a written consent for the publication of this article was obtained from the patients. The consent was written in Japanese for better understanding by the patient. The consent form will be provided to the editors of this journal on request.

Results
=======

Within our department, 145 patients (men, 72; women, 73), each ≥85 years old and requiring resection of colorectal cancer, were selected for the study. As shown in [Table 2](#t002){ref-type="table"}, laparoscopic surgery accounted for ～75% of the procedures. Complications of any magnitude (Clavien-Dindo Grades I-V) developed in 23.4% (34/145) of patients. A detailed analysis of patients with (+) or without (−) complications is provided in [Table 3](#t003){ref-type="table"}. They did not differ significantly in age, sex, American Society of Anesthesiologists (ASA) physical status, preoperative carcinoembryonic antigen (CEA) level, or presence/absence of severe heart disease, lung disease, or diabetes. However, the body mass index (BMI) showed a slight downward tendency in the presence of complications; and in the group without complications, significantly more laparoscopic surgeries took place. Tumor locations, operative times, and blood loss volumes were similar for the two groups. In the scoring of surgical risk, no significant group-wise differences in NLR, PLR, or mGPS emerged, although a tendency for slightly lower PNI was shown by patients with complications. In terms of E-PASS, the PRS values did not differ significantly in the two groups, but the SSS and CRS (a composite of PRS and SSS) values were significantly higher in the group with complications.

###### 

Characteristics of the Patient Population.

  ------------------------------ ------------------------
  Male:female                    72:73
  Age, mean (range)              87.8 yrs (85-97 yrs)
  ASA 2/ASA 3                    126/19
  Laparoscopy/laparotomy         109/36
  Stage 0/1/2/3/4                1/32/57/44/11
  Operative time, mean (range)   175.3 min (32-482 min)
  Blood loss, mean (range)       60 mL (0-974 mL)
  Postoperative complication     
  Clavien-Dindo Grade I-V        34 cases (23.4%)
  ------------------------------ ------------------------

ASA, American Society of Anesthesiologists

###### 

Univariate Analysis of Patients in Terms of Postoperative Complications.

  -----------------------------------------------------------------------------------
  Variable                        Complication (+)\   Complication (−)\   *P*-value
                                  (n = 34)            (n = 111)           
  ------------------------------- ------------------- ------------------- -----------
  Age (years)                     87 (85-94)          87 (85-97)          NS

  Sex (male/female)               16/18               56/55               NS

  ASA 2/ASA 3                     29/5                97/14               NS

  CEA                             4.3 (1.2-111.3)     4.8 (0.9-2426.6)    NS

  BMI                             20.6 (16.3-29.0)    21.6 (14.9-33.3)    0.081

  Heart disease (yes/no)          1/33                1/110               NS

  Pulmonary disease (yes/no)      2/32                2/109               NS

  Diabetes mellitus (yes/no)      5/29                18/93               NS

  Laparoscopic surgery (yes/no)   21/13               88/23               0.039

  Tumor location (C/A/T/D/S/R)    1/8/3/3/7/12        16/30/12/6/26/21    NS

  TNM stage (0/I/II/III/IV)       0/5/11/14/4         1/27/46/30/7        NS

  Operative time (min)            182 (32-329)        160 (52-482)        NS

  Blood loss (mL)                 15 (0-642)          5 (0-974)           NS

  Surgical risk scoring system                                            

  E-PASS PRS                      0.5098              0.5059              NS

                                  (0.3579-1.2034)     (0.3579-1.1098)     

  E-PASS SSS                      −0.1515             −0.2035             0.005

                                  (−0.2600-0.4233)    (−0.2990-0.5933)    

  E-PASS CRS                      0.0919              −0.0484             0.018

                                  (−0.2400-0.5623)    (−0.257-0.8788)     

  NLR                             2.687               2.777               NS

                                  (0.9483-12.608)     (1.0453-16.336)     

  PLR                             216.2               174.4               NS

                                  (60.818-487.18)     (53.939-718.21)     

  PNI                             42.415              44.295              0.076

                                  (22.375-53.525)     (25.005-57.81)      

  mGPS (0 and 1/2)                32/2                108/3               NS
  -----------------------------------------------------------------------------------

ASA, American Society of Anesthesiologists; CEA, carcinoembryonic antigen; BMI, body mass index; C/A/T/D/S/R: cecum/ascending/transverse/descending/sigmoid/rectum; E-PASS, Estimation of Physiologic Ability and Surgical Stress; PRS, preoperative risk score; SSS, surgical stress score; CRS, comprehensive risk score; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; PNI, prognostic nutritional index; mGPS, modified Glasgow Prognostic Score

We determined by ROC analysis CRS = −0.0580 as the cutoff value for the E-PASS CRS. The sensitivity and specificity of CRS = −0.0580 was 0.706 and 0.532, respectively. The area under the curve (AUC) of the model for E-PASS CRS was 0.634 ([Figure 2](#g002){ref-type="fig"}). Based on this cutoff value for the E-PASS CRS (−0.0580), we also assigned patients to low-scoring (LSG, n = 69) and high-scoring (HSG, n = 76) groups for analysis of short-term postoperative results ([Table 4](#t004){ref-type="table"}). These groups did not differ significantly in age, sex, preoperative CEA level, BMI, or presence/absence of severe heart or lung disease. As a matter of course (inherent to the CRS formula), the ASA 2/ASA 3 ratio, performance status, and diabetes comorbidity rate were high in the HSG. However, laparoscopic surgery was performed more frequently in LSG members. No significant group differences in tumor locations and TNM stages were evident. Although the operative times of the two groups were similar, blood loss was greater in the HSG. HSG members had a higher postoperative complication rate than LSG members, and the length of postoperative hospital stay was longer. The survival curves of both groups are plotted in [Figure 3](#g003){ref-type="fig"}. Survival was somewhat lower for HSG (vs. LSG) members, falling short of significance. In multivariate analysis, the HSG was associated with a higher chance of developing complications (odds ratio \[OR\] 2.776, 95% confidence interval \[95% CI\] 1.214-6.351, p = 0.016) ([Table 5](#t005){ref-type="table"}).

![Receiver operating curve analysis for postoperative complications. Area under the curve (AUC) of E-PASS (CRS) is 0.634.](2432-3853-4-0137-g002){#g002}

###### 

Univariate Analysis of Patients Stratified by E-PASS Comprehensive Risk Score (CRS).

  -----------------------------------------------------------------------------------------
  Variable                           Low-scoring group\   High-scoring group\   *P*-value
                                     (n = 69)             (n = 76)              
  ---------------------------------- -------------------- --------------------- -----------
  Age (years)                        87 (85-94)           87 (85-97)            NS

  Sex (male/female)                  33/36                39/37                 NS

  ASA 2/ASA 3                        66/3                 60/16                 0.003

  Peformance status (0/1-4)          54/15                28/48                 \<0.001

  CEA                                4.5 (1.2-2426.6)     4.8 (0.9-111.3)       NS

  BMI                                21.83 (15.7-33.3)    21.4 (14.9-29.3)      NS

  Heart disease (yes/no)             0/69                 2/74                  NS

  Pulmonary disease (yes/no)         0/69                 4/72                  0.073

  Diabetes mellitus (yes/no)         6/63                 17/59                 0.024

  Laparoscopic surgery (yes/no)      69/0                 40/36                 0.0001

  Tumor location (C/A/T/D/S/R)       9/17/7/3/18/15       8/20/9/6/15/18        NS

  TNM stage (0/I/II/III/IV)          0/18/27/21/3         1/14/30/23/8          NS

  Operative time (min)               153 (82-290)         180 (32-482)          NS

  Blood loss (mL)                    5 (0-302)            30 (0-974)            0.0001

  Postoperative complication (+/−)   10/59                24/52                 0.015

                                     14.49%               31.58%                

  Postoperative hospital stay        7 (5-16)             8 (4-86)              0.005
  -----------------------------------------------------------------------------------------

ASA, American Society of Anesthesiologists; CEA, carcinoembryonic antigen; BMI, body mass index; C/A/T/D/S/R: cecum/ascending/transverse/descending/sigmoid/rectum; E-PASS, Estimation of Physiologic Ability and Surgical Stress

![Overall survival plotted by E-PASS CRS: tendency for lower survival in HSG (vs. LSG).](2432-3853-4-0137-g003){#g003}

###### 

Multivariate Logistic Regression Analysis Evaluating Possible Risk Factors Associated with Complication.

  -----------------------------------------------------------------------------------
                     Partial regression\   Odds ratio   95% confidence\   *P*-value
                     coefficient                        interval          
  ------------------ --------------------- ------------ ----------------- -----------
  CRS (HSG vs LSG)   1.021                 2.776        1.214-6.351       0.016

  constant           −1.775                0.169                          0.000
  -----------------------------------------------------------------------------------

Model chi-squared test, p \< 0.05

CRS, comprehensive risk score; HSG, high-score group; LSG, low-score group

It is self-evident that laparoscopic surgery results in lower SSS and CRS. Therefore, we further examined whether E-PASS is effective even in open surgery. We determined by ROC analysis CRS = 0.2955 as the cutoff value for the E-PASS CRS. The sensitivity and specificity of CRS = 0.2955 was 0.615 and 0.261, respectively. The AUC of the model for E-PASS CRS was 0.605 ([Figure 4](#g004){ref-type="fig"}). Based on this, we also assigned patients to LSG (n = 22) and HSG (n = 14) for analysis of short-term postoperative results ([Table 6](#t006){ref-type="table"}). As with the previous study (the first examination including laparoscopy and open surgery), the HSG had poor performance status. Although there was no difference in the operation time between the two groups, the amount of bleeding was higher in the HSG. The postoperative complication rate was higher in the HSG than in the LSG (57.14% vs. 22.73%). As a result, the length of postoperative hospital stay was longer in the HSG.

![Receiver operating curve analysis for postoperative complications: focused on only laparotomy. Area under the curve (AUC) of E-PASS (CRS) is 0.605.](2432-3853-4-0137-g004){#g004}

###### 

Univariate Analysis of Patients Stratified by E-PASS CRS Focused on Only Laparotomy.

  -----------------------------------------------------------------------------------------
  Variable                           Low-scoring group\   High-scoring group\   *P*-value
                                     (n = 22)             (n = 14)              
  ---------------------------------- -------------------- --------------------- -----------
  Age (years)                        86.8 (85-97)         86.6 (85-93)          NS

  Sex (male/female)                  11/11                9/5                   NS

  ASA 2/ASA 3                        21/1                 11/3                  NS

  Peformance status (0/1-4)          16/6                 2/12                  \<0.001

  CEA                                3.7 (0.9-85.8)       5.0 (2.8-108.4)       NS

  BMI                                22.0 (14.9-29.3)     19.9 (18.3-25.4)      NS

  Heart disease (yes/no)             0/22                 0/14                  NS

  Pulmonary disease (yes/no)         0/22                 1/13                  NS

  Diabetes mellitus (yes/no)         1/21                 3/11                  NS

  Tumor location (C/A/T/D/S/R)       4/4/3/4/5/2          2/4/1/0/3/4           NS

  TNM stage (0/I/II/III/IV)          0/2/13/5/2           1/2/6/3/2             NS

  Operative time (min)               121.5 (60-256)       144.5 (32-462)        NS

  Blood loss (mL)                    54.5 (0-441)         188 (5-974)           0.017

  Postoperative complication (+/−)   5/17                 8/6                   0.036

                                     22.73%               57.14%                

  Postoperative hospital stay        7 (5-19)             11.5 (4-86)           0.025
  -----------------------------------------------------------------------------------------

ASA, American Society of Anesthesiologists; CEA, carcinoembryonic antigen; BMI, body mass index; C/A/T/D/S/R: cecum/ascending/transverse/descending/sigmoid/rectum; E-PASS, Estimation of Physiologic Ability and Surgical Stress; CRS, comprehensive risk score

Discussion
==========

In the realm of colorectal or gastric cancer surgery, much of the evidence indicates that elderly individuals are disadvantaged, showing higher postoperative complication and perioperative death rates than a younger population due to comorbidities\[[@B8]-[@B10]\]. Still, the premise that advanced age itself is a risk factor has been strongly disputed\[[@B11]-[@B15]\]. According to Banysch et al., colorectal surgery may be safely performed in patients past the age of 80 if the ASA status is good and there are no grave comorbid conditions\[[@B16]\]. Other sources have also claimed that lower BMI imparts high risk in the elderly population\[[@B17]\], and that low PNI heightens risks of postoperative complications and mortality after colorectal cancer surgery\[[@B18],[@B19]\]. Unfortunately, many ambiguities exist with regard to the types of patients warranting special perioperative attention and specific measures to reduce surgical risks.

Given these issues, various scoring systems have been used to predict the risk of perioperative complications. Recently, reports have surfaced on the utility of E-PASS in this setting\[[@B20]-[@B22]\]. In our study, we examined the super elderly, 85 years of age or older, and tried to identify risk factors other than age, and both SSS and CRS were significantly higher in patients who developed postoperative complications. The frequency of such complications, and PRS values as well, are known to increase with age; but the PRS is a patient-defined factor, difficult for surgeons to control. In order to lower the SSS, a focus on laparoscopic surgery\[[@B23]\] and shorter operative time is needed. Tominaga et al. have identified a CRS cutoff value of 0.2 at which and beyond postoperative complications are more likely\[[@B21]\]. Similarly, Yamamoto et al. have observed worse patient survival at CRS values of ≥0.05 than at values of \<0.05\[[@B22]\]. We examined high- and low-scoring patient subsets, based on the cutoff value calculated from the ROC curve for the E-PASS CRS (−0.0580), determining a lower survival rate in high-scoring patients. The overall survival rate in LSG was better (but not significantly) than that in HSG (p = 0.071). Furthermore, Dekker et al. seemed to achieve a 1-year survival rate in elderly patients after radical colorectal cancer resection that was on par with survival in young patients, so the care delivered perioperatively and up to 1 year after surgery is critical\[[@B24]\]. This highlights the importance of efforts to lower the SSS and the need for more diligent postoperative management if SSS and CRS metrics are high. To reduce SSS, laparoscopic approach can be followed instead of laparotomy and the amount of blood loss can be controlled as much as possible. However, the universal threshold for CRS could not be determined from this study alone.

Limitation: Owing to the nature of our hospital, extreme comorbidities are seldom encountered, and ～90% of all surgical procedures are laparoscopic, explaining the low CRS values at baseline. Therefore, the surgery results may be positive, even within the same study of older individuals \>85 years. It is important to consider that the same elderly individuals aged \>85 years are not indicated for cancer resection if their general condition is poor; they were not included in this study. A greater number and a higher diversity of patients must be studied going forward to better delineate CRS thresholds.

Conclusion
----------

Our data suggest that the E-PASS scoring system has potential as a reliable predictor of postoperative complications in super elderly patients subjected to colorectal cancer surgery.
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